Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin Over 4 Years Despite Greater Weight Gain: Observations from A Diabetes Outcome Progression Trial (ADOPT)
Kahn, S. E., Haffner, S. M., Viberti, G., Herman, W. H., Lachin, J. M., Kravitz, B. G., Yu, D., Paul, G., Holman, R. R., Zinman, B.Volume:
33
Language:
english
Journal:
Diabetes Care
DOI:
10.2337/dc09-1661
Date:
January, 2010
File:
PDF, 262 KB
english, 2010